Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06557590
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-14
Brief Title:
18F-FAPI-04 PETCT and PETMR in Patients With Various Types of Malignant Tumors
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Preliminary Study on the Diagnostic Value of 18F-FAPI-04 PETCT and PETMR in Patients With Various Types of Malignant Tumors
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the potential usefulness of 18F-FAPI-04 positron emission tomographycomputed tomography PETCT and positron emission tomographymagnetic resonance imaging PETMRfor the diagnosis of primary and metastatic lesions detection of recurrence or assessment of pathologic response in various types of cancer
Detailed Description:
Subjects with various types of cancer underwent 18F-FAPI-04 PETCT and PETMR imaging either for an initial assessment recurrence detection or assessment of pathologic response Tumor uptake was quantified by the maximum standard uptake value SUVmax and tumor to background TBR Using histopathology and follow-up as gold standard the sensitivity specificity positive predictive value PPV negative predictive value NPV and accuracy of 18F-FAPI-04 PETCT and PETMR were calculated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None